Log on / register
Feedback | Support | My details
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.
Tischkowitz M, Brunet JS, Bégin LR, Huntsman DG, Cheang MC, Akslen LA, Nielsen TO, Foulkes WD
BMC Cancer 2007, 7:134
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
37%37%


 Research article    
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors
Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, Fulton RS, Lee MM, Ambrosone CB, Caan BJ
Breast Cancer Research 2009, 11:R31 (22 May 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
2.
37%37%


 Research article    
Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers
Toyama T, Yamashita H, Kondo N, Okuda K, Takahashi S, Sasaki H, Sugiura H, Iwase H, Fujii Y
BMC Cancer 2008, 8:309 (25 October 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
3.
37%37%


 Letter    
Are triple-negative tumours and basal-like breast cancer synonymous?
Rakha EA, Tan DSP, Foulkes WD, Ellis IO, Tutt A, Nielsen TO, Reis-Filho JS
Breast Cancer Research 2007, 9:404 (30 November 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.